首页> 外国专利> TREATMENT WITH LYS-PLASMINOGEN OF REPERFUSION INJURY AND BRAIN EDEMA CAUSED BY ISCHEMIA

TREATMENT WITH LYS-PLASMINOGEN OF REPERFUSION INJURY AND BRAIN EDEMA CAUSED BY ISCHEMIA

机译:溶血性纤溶酶原对缺血性脑损伤的再灌注损伤和脑水肿的治疗

摘要

A treatment of ischemia and the attendant reperfusion injury entails the administration plasmin and plasmin-forming proteins, including lys-plasminogen and similar substances. Lys-plasminogen, which can be obtained from the proteolytic cleavage of glu-plasminogen, has been found to have a protective effect on tissue that has been injured by ischemic conditions. The administration of lys-plasminogen can used to treat subjects during the time of reperfusion and after reperfusion has already occurred. Lys-plasminogen also can be administered in conjunction with clot lysis therapies, such as those that employ tissue plasminogen activator and the like. IMAGE
机译:缺血和随之而来的再灌注损伤的治疗需要施用纤溶酶和纤溶酶形成蛋白,包括溶血纤溶酶原和类似物质。可以从glu-纤溶酶原的蛋白水解裂解中获得的Lys-纤溶酶原被发现对缺血性损伤的组织具有保护作用。溶血纤维蛋白溶酶原的施用可用于在再灌注期间和已经发生再灌注之后治疗受试者。溶血纤溶酶原也可以与凝块溶解疗法联合施用,例如采用组织纤溶酶原激活剂等的那些。 <图像>

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号